Search


Current filters:





Start a new search
Add filters:

Use filters to refine the search results.


Results 1-9 of 9 (Search time: 0.003 seconds).
  • previous
  • 1
  • next
Item hits:
PreviewIssue DateTitleAuthor(s)
2013Salvage second hematopoietic cell transplantation in myelomaMichaelis, L.; Saad, A.; Zhong, X.; Le-Rademacher, J.; Freytes, C.; Marks, D.; Lazarus, H.; Bird, J.; Holmberg, L.; Kamble, R.; Kumar, S.; Lill, M.; Meehan, K.; Saber, W.; Schriber, J.; Tay, J.; Vogl, D.; Wirk, B.; Savani, B.; Gale, R.; et al.
2011Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancerDeenen, M.; Tol, J.; Burylo, A.; Doodeman, V.; de Boer, A.; Vincent, A.; Guchelaar, H.; Smits, P.; Beijnen, J.; Punt, C.; Schellens, J.; Cats, A.
2014Preoperative factors predicting clinical outcome following laparoscopic fundoplicationStaehelin, A.; Zingg, U.; Devitt, P.; Esterman, A.; Smith, L.; Jamieson, G.; Watson, D.
2015Influence of fracture stability on early patient mortality and reoperation after Pertrochanteric and intertrochanteric hip fracturesChehade, M.J.; Carbone, T.; Awward, D.; Taylor, A.; Wildenauer, C.; Ramasamy, B.; McGee, M.
2012Impact of age on choice of chemotherapy and outcome in advanced colorectal cancerKhattak, M.; Townsend, A.; Beeke, C.; Karapetis, C.; Luke, C.; Padbury, R.; Maddern, G.; Roder, D.; Price, T.
2011Safety and pharmacokinetics of motesanib in combination with gemcitabine and erlotinib for the treatment of solid tumors: a phase 1b studyKotasek, D.; Tebbutt, N.; Desai, J.; Welch, S.; Siu, L.; McCoy, S.; Sun, Y.; Johnson, J.; Adewoye, A.; Price, T.
2015Recent trends in early stage response to combination antiretroviral therapy in AustraliaMcManus, H.; Hoy, J.; Woolley, I.; Boyd, M.; Kelly, M.; Mulhall, B.; Roth, N.; Petoumenos, K.; Law, M.
2016Active foot synovitis in patients with rheumatoid arthritis: unstable remission status, radiographic progression, and worse functional outcomes in patients with foot synovitis in apparent remissionWechalekar, M.; Lester, S.; Hill, C.; Lee, A.; Rischmueller, M.; Smith, M.; Walker, J.; Proudman, S.
2017Modelling predictors of molecular response to frontline imatinib for patients with chronic myeloid leukaemiaBanjar, H.; Ranasinghe, D.; Brown, F.; Adelson, D.; Kroger, T.; Leclercq, T.; White, D.; Hughes, T.; Chaudhri, N.; Speletas, M.